1. Fc-Mediated Effector Function Contributes to the in Vivo Antiviral Effect of an HIV Neutralizing Antibody. Asokan, M., J. Dias, C. Liu, A. Maximova, K. Ernste, A. Pegu, K. McKee, W. Shi, X. Chen, C. Almasri, W. Promsote, D.R. Ambrozak, L. Gama, J. Hu, D.C. Douek, J.P. Todd, J.D. Lifson, S. Fourati, R.P. Sekaly, A.R. Crowley, M.E. Ackerman, S.H. Ko, D. Kilam, E.A. Boritz, L.E. Liao, K. Best, A.S. Perelson, J.R. Mascola, and R.A. Koup. Proceedings of the National Academy of Sciences of the United States of America, 2020. 117(31): p. 18754-18763. PMID[32690707]. [PMC7414046].
[PubMed]. HIV_08_2020.
2. Highly Synergistic Drug Combination Prevents Vaginal HIV Infection in Humanized Mice. Baum, M.M., C.M. Ramirez, J.A. Moss, M. Gunawardana, M. Bobardt, and P.A. Gallay. Scientific Reports, 2020. 10(1): 12995. PMID[32747682]. PMCID[PMC7400648].
[PubMed]. HIV_08_2020.
3. Development of a Selective HDAC Inhibitor Aimed at Reactivating the HIV Latent Reservoir. Clausen, D.J., J. Liu, W.S. Yu, J.L. Duffy, C.E.C. Chung, R.W. Myers, D.J. Klein, J. Fells, K. Holloway, J. Wu, G.X. Wu, B.J. Howell, R.J.O. Barnard, and J. Kozlowski. Bioorganic & Medicinal Chemistry Letters, 2020. 30(17): 127367. PMID[32738976].
[PubMed]. HIV_08_2020.
4. Design, Synthesis, and Biological Characterization of a New Class of Symmetrical Polyamine-based Small Molecule CXCR4 Antagonists. Fang, X., Q. Meng, H. Zhang, B. Liang, S. Zhu, J. Wang, C. Zhang, L.S. Huang, X. Zhang, R.T. Schooley, J. An, Y. Xu, and Z. Huang. European Journal of Medicinal Chemistry, 2020. 200: 112410. PMID[32492596].
[PubMed]. HIV_08_2020.
5. Synthesis and Antiviral Evaluation of 3'-Fluoro-5'-norcarbocyclic nucleoside phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents. Geant, P.Y., J.P. Uttaro, C. Périgaud, and C. Mathé. Molecules, 2020. 25(16): E3708. PMID[32823897].
[PubMed]. HIV_08_2020.
6. Synthesis and Antiviral Evaluation of 3'-C-Hydroxymethyl-3'-O-phosphonomethyl-beta-D-5'-deoxyxylose nucleosides. Ji, S.J., S. Wang, H.X. Wang, Y.Y. Gao, W.K. Xu, X.Y. Huo, P. Herdewijn, and F.W. Liu. European Journal of Organic Chemistry, 2020. 2020(31): p. 4995-5002.ISI[000550500100001].
[WOS]. HIV_08_2020.
7. Lipophilic Triphosphate Prodrugs of Various Nucleoside Analogues. Jia, X., D. Schols, and C. Meier. Journal of Medicinal Chemistry, 2020. 63(13): p. 6991-7007. PMID[32515595].
[PubMed]. HIV_08_2020.
8. Structure-Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIs. Kang, D., Y. Sun, N.A. Murugan, D. Feng, F. Wei, J. Li, X. Jiang, E. De Clercq, C. Pannecouque, P. Zhan, and X. Liu. ACS Infectious Diseases, 2020. 6(8): p. 2225-2234. PMID[32619096].
[PubMed]. HIV_08_2020.
9. A Broad-spectrum Antiviral Peptide Blocks Infection of Viruses by Binding to Phosphatidylserine in the Viral Envelope. Luteijn, R.D., P. Praest, F. Thiele, S.M. Sadasivam, K. Singethan, J.W. Drijfhout, C. Bach, S.M. de Boer, R.J. Lebbink, S. Tao, M. Helfer, N.C. Bach, U. Protzer, A.I. Costa, J.A. Killian, I. Drexler, and E. Wiertz. Cells, 2020. 9(9): E1989. PMID[32872420].
[PubMed]. HIV_08_2020.
10. Phosphate Derivatives of 3-Carboxyacylbetulin: Synthesis, in Vitro anti-HIV and Molecular Docking Study. Marciniec, K., E. Chrobak, A. Dąbrowska, E. Bębenek, M. Kadela-Tomanek, P. Pęcak, and S. Boryczka. Biomolecules, 2020. 10(8): E1148. PMID[32764519].PMCID[PMC7464173].
[PubMed]. HIV_08_2020.
11. Design and Synthesis of Novel 1-Substituted-3-(3-(3-nitrophenyl)-4-oxo-3,4-dihydrobenzopyrimidin-2-yl amino) isothioureas for Their anti-HIV, Antibacterial Activities, Graph Theoretical Analysis, in Silico Modeling, Prediction of Toxicity and Metabolic Studies. Narendhar, B., V. Alagarsamy, and C. Krishnan. Drug Research, 2020. 70(8): p. 348-355. PMID[32559773].
[PubMed]. HIV_08_2020.
12. Bioactive Lignans from Hypoestes aristata. Ramabulana, T., L.M. Scheepers, T. Moodley, V.J. Maharaj, A. Stander, N. Gama, D. Ferreira, M.S. Sonopo, and M.A. Selepe. Journal of Natural Products, 2020. 83(8): p. 2483-2489. PMID[32786879].
[PubMed]. HIV_08_2020.
13. Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-Tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere. Rusere, L.N., G.J. Lockbaum, M. Henes, S.K. Lee, E. Spielvogel, D.N. Rao, K. Kosovrasti, E.A. Nalivaika, R. Swanstrom, N. Kurt Yilmaz, C.A. Schiffer, and A. Ali. Journal of Medicinal Chemistry, 2020. 63(15): p. 8296-8313. PMID[32672965].
[PubMed]. HIV_08_2020.
14. HIV-1 Integrase Inhibitors That Are Active against Drug-resistant Integrase Mutants. Smith, S.J., X.Z. Zhao, D.O. Passos, D. Lyumkis, T.R. Burke, Jr., and S.H. Hughes. Antimicrobial Agents and Chemotherapy, 2020. 64(9):e00611-20. PMID[32601157].
[PubMed]. HIV_08_2020.
15. Gliotoxin, Identified from a Screen of Fungal Metabolites, Disrupts 7SK snRNP, Releases P-TEFb, and Reverses HIV-1 Latency. Stoszko, M., A.M.S. Al-Hatmi, A. Skriba, M. Roling, E. Ne, R. Crespo, Y.M. Mueller, M.J. Najafzadeh, J. Kang, R. Ptackova, E. LeMasters, P. Biswas, A. Bertoldi, T.W. Kan, E. de Crignis, M. Sulc, J.H.G. Lebbink, C. Rokx, A. Verbon, W. van Ijcken, P.D. Katsikis, R.J. Palstra, V. Havlicek, S. de Hoog, and T. Mahmoudi. Science Advances, 2020. 6(33): p. eaba6617. PMID[32851167]. PMCID[PMC7423394].
[PubMed]. HIV_08_2020.
16. Discovery of Novel Integrase-LEDGF/p75 Allosteric Inhibitors Based on a Benzene Scaffold. Sugiyama, S., T. Iwaki, Y. Tamura, K. Tomita, E. Matsuoka, S. Arita, T. Seki, T. Yoshinaga, and T. Kawasuji. Bioorganic & Medicinal Chemistry, 2020. 28(17): 115643. PMID[32773094].
[PubMed]. HIV_08_2020.
17. Synthesis, Crystal Structure and Biological Activity of Dimethyl 1-Methyl-1,4-dihydroquinoline-3,4-dicarboxylate and Tetramethyl pyrrolo-[1,2-a]quinoline-2,3,4,5-tetracarboxylate. Xu, X.M., Z.G. Luo, X.X. Han, Q.N. Liu, and R. Li. Chinese Journal of Structural Chemistry, 2020. 39(7): p. 1271-1276. ISI[000551343300011].
[WOS]. HIV_08_2020.
Patent Citations
18. Novel Triterpene Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, P.R. Adulla, and B.R. Kasireddy. Patent. 2020. 2020-IB51048 2020165741: 113pp.
[Patent]. HIV_08_2020.
19. Preparation of Pyridopyrimidines as Inhibitors of Human Immunodeficiency Virus Replication. Iwuagwu, C. Patent. 2020. 2020-IB50743 2020157692: 49pp.
[Patent]. HIV_08_2020.